Oliver McAteer
Jul 17, 2019

Havas is first holding company to launch major cannabis consultancy

The multi-office US-based venture, dubbed Havas ECS, will serve the use-specific needs of pharmaceutical, health, wellness and brand communities.

Havas is first holding company to launch major cannabis consultancy

Havas has become the first holding company to launch a major cannabis consultancy. 

The new unit, called Havas ECS and operated under the Havas Health & You brand, will serve the use-specific needs of pharmaceutical, health, wellness and brand communities, powered by expertise and a network of medical advisors skilled in the application of cannabinoid medicine.  

Around 64 million Americans have tried cannabidiol or CBD, made from legal hemp, 386 investigational cannabinoid studies are registered with FDA, and two-thirds of U.S. states and 22 countries have legalized marijuana for medical purposes.

Rob Dhoble, who is leading the multi-office venture, said: "Cannabinoid and cannabis use, for wellness, self-care, and healthcare, has reached new levels of relevance, and will continue to grow as new products, including foods, beverages, prescription medicines, and non-prescription remedies are introduced. 

"A new cannabinoid reality has arrived, now with a major network validating the space, helping clients seize marketplace opportunities, assess customer insights, and even plan for potential threats.  

"Havas ECS addresses the urgent need for a communications advisory and training company that integrates foundational endocannabinoid science with the relevant real-world learnings of scientists and medical practitioners."

There are still massive gaps in the scientific understanding across the medical, public health, wellness, regulatory, patient advocacy and brand communities. In fact, only 13 percent of medical schools offer any instructional material on the human endocannabinoid system (ECS), an essential biological system only discovered in the mid-1990s that regulates many aspects of human health and well-being.  

Dhoble and his team will serve to advance the understanding of cannabinoid health and wellness, with science-based education and communication programs that frame and elevate the cannabinoid conversation, and increase the understanding of treatments and ECS-related medical conditions. 

The company will be active immediately, and plans to host its first educational conference this fall.

Donna Murphy, global CEO of Havas Health & You, added: "With the lightning fast expansion of cannabis and cannabinoid brands, our network, and industry, will benefit deeply from a central source for science-based understanding. 

"As the world’s largest health and wellness network, it’s incumbent on us to stay ahead of the curve, keeping our clients, partners and the broader brand community in an advantageous position through continuous evolution and adaptation."

Source:
Campaign US

Related Articles

Just Published

1 hour ago

Purpose, laughs, and boppable tunes: Spikes jury ...

SPIKES ASIA X CAMPAIGN: Presidents and members of several Spikes Asia juries share the top trends they spotted in the jury Zoom rooms, with video examples.

2 hours ago

Crash Course: How to tell engaging short-form stories

To round off a week of creativity-themed content during Spikes Asia X Campaign festival, this Crash Course provides useful tips on how to build story arcs and create thumb-stopping campaigns for short-form.

2 hours ago

Lessons from Tesla, Apple and yoga (yes, yoga) in ...

SPIKES ASIA X CAMPAIGN: Creatives need to drive relevance for sustainable options, instead of virtue-signalling about sustainability, argues Gulshan Singh of FCB Interface.

2 hours ago

Spikes Asia Awards 2021: Campaign's contenders 3

As the juries make their final selections ahead of the March 1 winners announcement, Campaign Asia-Pacific's editorial team has once again scoured through the 2021 shortlist to pick out the work we expect to win.